HODGKIN'S DISEASE MIXED CELLULARITY RECURRENT

This adverse event was reported 2 times

These drugs are most commonly taken by patients reporting HODGKIN'S DISEASE MIXED CELLULARITY RECURRENT:

# Drug Count
0 BLEOMYCIN 2
1 BLEOMYCIN SULFATE 2
2 METHOTREXATE 2
3 METHOTREXATE SODIUM 2
4 CISPLATIN 1
5 CYCLOPHOSPHAMIDE 1
6 CYCLOPHOSPHAMIDE FOR INJECTION 1
7 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 1
8 CYTARABINE 1
9 ETOPOSIDE 1
See all common drugs associated with HODGKIN'S DISEASE MIXED CELLULARITY RECURRENT

HODGKIN'S DISEASE MIXED CELLULARITY RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PROCARBAZINE HYDROCHLORIDE 1 0.0002
1 BLEOMYCIN SULFATE 2 0.0002
2 MERCAPTOPURINE 1 0.0001
3 CYTARABINE 1 0.0000
4 ETOPOSIDE 1 0.0000
5 CISPLATIN 1 0.0000
6 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
7 CYCLOPHOSPHAMIDE 1 0.0000
8 PREDNISOLONE ORAL SOLUTION 1 0.0000
9 METHOTREXATE SODIUM 2 0.0000
See all drugs enriched for association with HODGKIN'S DISEASE MIXED CELLULARITY RECURRENT

HODGKIN'S DISEASE MIXED CELLULARITY RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 1 0.0000
1 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
2 Alkylating Drug [EPC] 1 0.0000
3 Platinum-based Drug [EPC] 1 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
5 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with HODGKIN'S DISEASE MIXED CELLULARITY RECURRENT